NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Approved targeted drugs for HER2 -mutant NSCLC include trastuzumab deruxtecan (T-DXd, Enhertu) -- which is highly effective ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

From 2003-2017, incidence rates for six of 13 cancers assessed rose among younger adults (ages 20-49) in over 75% of the ...

Scientists link poor oral health to dramatically higher pancreatic cancer risk, emphasizing the importance of regular ...

Oral cancer remains a serious health concern, often diagnosed too late for effective treatment, even though the mouth is ...

Study reveals low awareness of oral cancer symptoms and government screenings among patients, highlighting need for public ...

Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of ...

How Interdisciplinary Care Helped a Dental Patient Recover from Mouth Cancer ...

Eli Lilly and Company (NYSE: LLY) today announced results from the primary overall survival (OS) analysis of the Phase 3 ...

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free ...

Preliminary Results Yield 43% Overall Response Rates (via RECIST) in the Efficacy Population Data Demonstrate REM-422, the ...